Rory J. McCrimmon
McCrimmon, Rory J.
McCrimmon, Rory John
VIAF ID: 303900594 (Personal)
Permalink: http://viaf.org/viaf/303900594
Preferred Forms
-
-
- 100 1 _ ‡a McCrimmon, Rory J.
-
- 100 1 _ ‡a McCrimmon, Rory John
- 100 0 _ ‡a Rory J. McCrimmon
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
AICAR and phlorizin reverse the hypoglycemia-specific defect in glucagon secretion in the diabetic BB rat. | |
AMP-activated protein kinase (AMPK) activator A-769662 increases intracellular calcium and ATP release from astrocytes in an AMPK-independent manner | |
AMPK modulates glucose-sensing in insulin-secreting cells by altered phosphotransfer to KATP channels | |
Amplified hormonal counterregulatory responses to hypoglycemia in rats after systemic delivery of a SUR-1-selective K(+) channel opener? | |
Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study | |
Anger state during acute insulin-induced hypoglycaemia. | |
Antecedent hypercortisolemia is not primarily responsible for generating hypoglycemia-associated autonomic failure | |
Appraisal of mood and personality during hypoglycaemia in human subjects. | |
Bace1-dependent amyloid processing regulates hypothalamic leptin sensitivity in obese mice. | |
Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission. | |
CD44 contributes to hyaluronan-mediated insulin resistance in skeletal muscle of high-fat-fed C57BL/6 mice | |
Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function | |
Chronic exposure to KATP channel openers results in attenuated glucose sensing in hypothalamic GT1-7 neurons. | |
Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. | |
Continuous hypothalamic K(ATP) activation blunts glucose counter-regulation in vivo in rats and suppresses K(ATP) conductance in vitro | |
Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation | |
Dominantly inherited syndrome comprising partially absent eye muscles, hydrocephaly, skeletal abnormalities, and a distinctive facial phenotype | |
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study | |
Effects of acute hypoglycaemia on auditory information processing in adults with Type I diabetes | |
Effects of recurrent antecedent hypoglycaemia and chronic hyperglycaemia on brainstem extra-cellular glucose concentrations during acute hypoglycaemia in conscious diabetic BB rats | |
Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial | |
An estimate of lifetime cognitive change and its relationship with diabetes health in older adults with type 1 diabetes: preliminary results | |
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010 | |
Ethnicity and risk of cardiovascular disease (CVD): 4.8 year follow-up of patients with type 2 diabetes living in Scotland | |
Exercise management in type 1 diabetes: a consensus statement | |
Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2). | |
Frequency of thyroid dysfunction in diabetic patients: value of annual screening | |
Glucose sensing during hypoglycemia: lessons from the lab. | |
Glycaemic benefit of iGlarLixi in insulin-naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan-O randomized trial | |
Glycaemic control trends in people with type 1 diabetes in Scotland 2004-2016 | |
High-Intensity Exercise as a Dishabituating Stimulus Restores Counterregulatory Responses in Recurrently Hypoglycemic Rodents. | |
Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance | |
Hypoglycaemia: exercise for the brain? | |
Hypoglycaemia in clinical diabetes, 2014: | |
Hypoglycaemia, the most feared complication of insulin therapy. | |
Hypoglycaemic symptoms reported by children with type 1 diabetes mellitus and by their parents | |
Hypothalamic AMP-activated protein kinase activation with AICAR amplifies counterregulatory responses to hypoglycemia in a rodent model of type 1 diabetes. | |
Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses | |
Hypothalamic Fkbp51 is induced by fasting, and elevated hypothalamic expression promotes obese phenotypes | |
In-vivo correlations between skin metabolic oscillations and vasomotion in wild-type mice and in a model of oxidative stress | |
Influence of an early-onset age of type 1 diabetes on cerebral structure and cognitive function. | |
Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo | |
Inhibition of NFAT Signaling Restores Microvascular Endothelial Function in Diabetic Mice | |
Investigating the Relationship Between Type 2 Diabetes and Dementia Using Electronic Medical Records in the GoDARTS Bioresource | |
Long-term, intermittent, insulin-induced hypoglycemia produces marked obesity without hyperphagia or insulin resistance: a model for weight gain with intensive insulin therapy | |
Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice | |
Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia | |
Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes | |
Mouse hypothalamic GT1-7 cells demonstrate AMPK-dependent intrinsic glucose-sensing behaviour. | |
Nrf2-Mediated Neuroprotection Against Recurrent Hypoglycemia Is Insufficient to Prevent Cognitive Impairment in a Rodent Model of Type 1 Diabetes | |
Oleate induces KATP channel-dependent hyperpolarization in mouse hypothalamic glucose-excited neurons without altering cellular energy charge | |
Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin | |
The physiology and pathophysiology of the neural control of the counterregulatory response | |
Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor | |
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA. | |
Radix astragali (huangqi) as a treatment for defective hypoglycemia counterregulation in diabetes | |
RD Lawrence Lecture 2015 Old habits are hard to break: lessons from the study of hypoglycaemia. | |
Real-time Continuous Glucose Monitoring During a Hyperinsulinemic Hypoglycemic Clamp Significantly Underestimates the Degree of Hypoglycemia | |
Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo-RESOLVE) project | |
Renal and Cardiovascular Effects of sodium-glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial | |
Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study. | |
Saxagliptin co-therapy in C-peptide negative Type 1 diabetes does not improve counter-regulatory responses to hypoglycaemia | |
The Scylla and Charybdis of glucose control in childhood type 1 diabetes? | |
Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways | |
SGLT inhibitor adjunct therapy in type 1 diabetes | |
Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not w | |
Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin | |
Symptoms reported during experimental hypoglycaemia: effect of method of induction of hypoglycaemia and of diabetes per se | |
Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia | |
Testing the accelerator hypothesis: a new approach to type 1 diabetes prevention (adAPT 1) | |
Trends in type 2 diabetes incidence and mortality in Scotland between 2004 and 2013. | |
Type 2 diabetes, socioeconomic status and life expectancy in Scotland (2012-2014): a population-based observational study. | |
Update in the CNS response to hypoglycemia | |
Ventromedial hypothalamic nitric oxide production is necessary for hypoglycemia detection and counterregulation | |
Visual information processing during controlled hypoglycaemia in humans. |